Last Price$4.3(4.0%)
Market Cap$211.4B
1M Return
(14.6%)
vs (2.4%) S&P 500
YTD Return
(76.7%)
vs 23.3% S&P 500
1Y Return
(83.5%)
vs 14.0% S&P 500
3Y Return
(76.4%)
vs 34.1% S&P 500
SLN Momentum Rating
SLN Momentum rating
3.6
SLN Momentum rating performance
SLN Price Performance and Momentum
Crunching data... Almost there!
Competing with SLN Stock Price Performance
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Momentum score | Last Price | 52w high | 52w low | 1d change | 1w change | 1m change | 3m change | 6m change | 1y change | 3y change | 5y change | 10y change | 3y CAGR | 5y CAGR | 10y CAGR | % of 52w high | % of 52w low |
$211.4B | 3.6 | $4.3 (4.0%) | $26.3 | $4.1 | (4.0%) | (11.3%) | (14.6%) | (43.7%) | (77.5%) | (83.5%) | (76.4%) | (77.8%) | (77.8%) | (38.2%) | (31.4%) | (31.4%) | 16.5% | 105.1% | |
$402.0B | 4.4 | $89.4 (1.4%) | $146.5 | $77.9 | (1.4%) | (1.3%) | 8.1% | (18.2%) | (34.4%) | (29.6%) | 76.2% | 207.5% | 337.2% | 20.8% | 25.2% | 15.9% | 61.0% | 114.8% | |
$125.5B | 3.0 | $483.3 0.7% | $516.7 | $392.8 | 0.7% | 0.3% | 2.8% | 5.8% | 1.6% | 14.0% | 105.1% | 111.7% | 291.3% | 27.0% | 16.2% | 14.6% | 93.5% | 123.0% | |
$74.0B | 4.1 | $684.9 (2.0%) | $1,201.8 | $663.9 | (2.0%) | (4.0%) | 2.7% | (8.6%) | (41.4%) | (29.5%) | 12.1% | 48.4% | 66.0% | 3.9% | 8.2% | 5.2% | 57.0% | 103.2% | |
$38.1B | 9.1 | $622.6 (0.3%) | $671.2 | $356.0 | (0.3%) | (0.6%) | (5.3%) | 2.7% | 21.1% | 59.5% | 128.6% | 322.5% | 2,607.0% | 31.7% | 33.4% | 60.2% | 92.8% | 174.9% | |
$31.3B | 4.6 | $243.5 (1.3%) | $300.6 | $143.3 | (1.3%) | (2.2%) | (11.3%) | (3.3%) | (4.0%) | 62.3% | 47.5% | 118.6% | 127.8% | 13.8% | 16.9% | 8.6% | 81.0% | 169.9% | |
$27.1B | 8.2 | $111.6 (1.2%) | $126.9 | $78.4 | (1.2%) | (4.6%) | (6.9%) | (3.5%) | 26.8% | 24.9% | (20.5%) | 193.8% | 693.8% | (7.4%) | 24.1% | 51.3% | 87.9% | 142.4% | |
$14.8B | 7.6 | $70.3 (4.4%) | $83.4 | $51.2 | (4.4%) | (5.1%) | (4.7%) | (2.5%) | 6.0% | 17.6% | 1.2% | (9.7%) | (20.1%) | 0.4% | (2.0%) | (2.2%) | 84.3% | 137.3% | |
$14.6B | 8.0 | $19.1 (7.5%) | $31.9 | $2.4 | (7.5%) | 1.5% | (4.3%) | 7.7% | 51.8% | 327.0% | 566.6% | 1,088.2% | 87.7% | 88.2% | 64.1% | 7.2% | 59.9% | 800.4% | |
$14.0B | 7.5 | $310.0 (3.1%) | $410.0 | $228.3 | (3.1%) | (13.5%) | (12.6%) | (15.9%) | (12.0%) | 35.5% | 77.2% | 209.4% | 96.5% | 21.0% | 25.3% | 7.0% | 75.6% | 135.8% | |
$1,846.9M | 9.0 | $226.7 0.0% | $246.0 | $129.5 | 0.0% | 2.0% | 23.3% | 4.7% | 40.9% | 39.9% | (6.5%) | 45.2% | 700.5% | (3.3%) | 7.7% | 29.7% | 92.1% | 175.0% |
FAQ
1. What is Silence Therapeutics plc (SLN) 1-month return?
Silence Therapeutics plc (SLN) 1-month return is (14.6%), compared to the (2.4%) return of the S&P 500.
2. What is Silence Therapeutics plc (SLN) year-to-date (YTD) return?
Silence Therapeutics plc (SLN) YTD return is (76.7%), compared to the 23.3% return of the S&P 500.
3. What is Silence Therapeutics plc (SLN) 1-year return?
Silence Therapeutics plc (SLN) 1-year return is (83.5%), compared to the 14.0% return of the S&P 500.
4. What is Silence Therapeutics plc (SLN) 3-year return?
Silence Therapeutics plc (SLN) 3-year return is (76.4%), compared to the 34.1% return of the S&P 500.